U.S. equities staged a significant rebound on Monday, October 13, 2025, as Wall Street clawed back substantial losses from Friday's sharp sell-off. The positive shift in investor sentiment was largely driven by President Donald Trump's softened rhetoric regarding trade tensions with China over the weekend. Major market indexes surged in afternoon trading, with technology stocks leading the charge.Afternoon Trading Activity and Major Index PerformanceAs the afternoon session progressed, all three major U.S. ...

Protagonist Therapeutics (NASDAQ:PTGX) dropped 5% after a report that the Johnson & Johnson (NYSE:JNJ) takeover price may be lower than the current share price. Blackstone is to speculated to be the private equity firm working with Johnson & Johnson ( ...

Market Overview - The S&P 500 increased by 1.3%, recovering nearly half of its previous drop, while the Dow Jones Industrial Average rose by 483 points (1.1%) and the Nasdaq composite gained 1.8% [1] - The market's movements reflect volatility similar to that seen in April, when significant tariff announcements were made by Trump [3] Trade Relations - Trump expressed a less confrontational stance towards China, indicating a desire to help rather than harm, following a period of heightened tensions over trade [1][2] - China responded by urging the U.S. to resolve differences through negotiations, emphasizing that it does not seek a tariff war but is prepared for one if necessary [2] Economic Indicators - The U.S. stock market had been primed for a drop, with concerns that stock prices had risen too high after a 35% increase in the S&P 500 since April [5] - Expectations for interest rate cuts by the Federal Reserve have also contributed to stock price increases since April [6] Company Performance - Broadcom saw a significant increase of 10.2% after announcing a collaboration with OpenAI to design custom AI accelerators [7] - The upcoming earnings reporting season is critical, with major companies like JPMorgan Chase, Johnson & Johnson, and United Airlines set to report their summer profits [8] - Fastenal's stock fell by 6.4% after reporting weaker-than-expected profits for the latest quarter [8] Analyst Insights - Bank of America strategist Savita Subramanian is optimistic about S&P 500 companies potentially exceeding profit expectations, citing a resilient U.S. economy and a weakening dollar that boosts overseas sales [9] Global Market Reactions - International stock markets showed mixed results, with Asian markets reacting negatively to Trump's tariff threats, while European indexes were also mixed following these developments [10]

Health care giant Johnson & Johnson (NYSE:JNJ) has had a good year with its shares trading near all-time highs. The company looks to keep a trend of beating analyst estimates when third-quarter financial results are reported before market open Tuesday.Here are the earnings estimates, what experts are saying ahead of the report and key items to watch.Earnings Estimates: Analysts expect Johnson & Johnson to report third-quarter revenue of $23.74 billion, up from $22.47 billion in last year's third quarter, ac ...

Johnson & Johnson’s (NYSE:JNJ) earnings report on Tuesday will set the tone for the third quarter pharma earnings, with investors looking for trends, including performance in the MedTech business, guidance and impact from tariffs. The New Brunswick, New Jersey-based pharmaceutical giant is expected to ...

It's been a busy week for Protagonist Therapeutics, Inc. (PGTX) in terms of news. They're a name that wouldn't have been on everyone's map before the interest shown by Johnson & Johnson ( JNJI hold a Master’s degree in Cell Biology and began my career working for several years as a lab technician in a drug discovery clinic, where I gained extensive hands-on experience in cell culture, assay development, and therapeutic research. That scientific foundation gave me an appreciation for the rigor and challenges ...

已持续15年的强生爽身粉致癌诉讼再现新案例，近日，美国医药巨头强生公司（Johnson & Johnson）因 其含滑石粉的爽身粉产品具有致癌性，被判赔偿9.66亿美元。 据多家媒体报道，2021年，美国加州居民梅·摩尔因患罕见癌症间皮瘤去世，其家人于同年起诉强生公 司，指控该公司婴儿爽身粉产品含有石棉纤维，导致摩尔患上罕见癌症。经过漫长的诉讼，2025年10月 7日，美国洛杉矶县法院一陪审团裁定，强生公司须赔偿家属9.66亿美元（约合68.8亿元人民币），这也 是强生爽身粉诉讼持续15年来，单一原告获赔金额最高的一起判决。 凤凰网财经援引法庭文件报道称，强生公司早在20世纪70年代便已知悉其滑石粉（爽身粉原料）中可能 含有石棉，但从未向公众披露这一风险。对于摩尔所患的间皮瘤，医学界普遍认为其与长期接触石棉密 切相关。原告律师表示："我们希望强生最终能为这些原本可以避免的悲剧承担责任。" 赛诺菲 雷尼替丁（Ranitidine）致癌诉讼案 赛诺菲与GSK（葛兰素史克）共同经营的Zantac（活性成分为雷尼替丁）于1983年作为处方药进入美国 市场，并于1996年成为一种非处方胃灼热治疗药物，该药物在2017年 ...

Key Takeaways Q3 MedTech growth at J&J should have been driven by strength in Cardiovascular and Surgery.New products and acquired units, Abiomed and Shockwave, are expected to have fueled further sales momentum.VBP impacts in China might have restrained J&J's MedTech profit performance in Q3.Johnson & Johnson's (JNJ) medical devices segment, known as MedTech, offers products in the orthopedics, surgery, cardiovascular and vision markets. The MedTech segment accounts for around 36% of J&J’s total revenues.I ...

The week ahead is heavily weighted with financials earnings, featuring major banks like JPMorgan Chase & Co. and Goldman Sachs Group Inc. (The) pre-market on Tuesday, alongside Johnson & Johnson. Wednesday and Thursday continue this trend with numerous financials reports, notably Bank of America Corporation on Wednesday and Taiwan Semiconductor Manufacturing Company Ltd. on Thursday pre-market, marking a high density of reports across these days.“` Disclaimer: This article is for informational purposes only ...

1. 10月13日(周一)美股盘前，美股三大股指期货齐涨。截至发稿，道指期货涨0.77%，标普500指数期货涨1.14%，纳指期货涨1.69%。 市场消息 美股迎关键财报周!六大行业绩成市场"试金石"，能否对冲政治僵局阴霾?受贸易战风险加剧、美国联邦政府停摆持续等因素影响，市场情 绪迅速恶化导致美股上周遭遇"黑色星期五"。在即将到来的一周里，由于华盛顿的政治僵局仍在持续，市场将无法获得若干关键经济数据 的更新，包括进口价格、零售销售和初请失业金等数据。美股新一轮财报季将于本周拉开帷幕，打头阵的美国六大银行——摩根大通、高 盛、摩根士丹利、美国银行、花旗以及富国银行——的业绩将成为焦点。市场预计得益于投行业务的强势复苏，加上美国经济的韧性令借 款人保持良好状态并支撑消费者和商业贷款部门，这六大银行的第三季度业绩将表现强劲。 牛市面临考验!期权市场预示美股将迎2022年以来最动荡财报季。美股投资者们再次为即将到来的财报季的股市波动做好了准备。数据显 示，对标普500 指数成分股公司的股票期权走势显示，公司业绩公布后，股价平均预计将波动 4.7%。这一波动幅度与 7 月份的情况较为接 近。当时，预计的股价变动幅度是 ...